A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy. (Q33467203)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Stephanie Corgnac

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Martine Pugniere

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Daniel Baty

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Isabelle Navarro-Teulon

10

object named as

Isabelle Navarro-Teulon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Caroline Bascoul-Mollevi

7

object named as

Caroline Bascoul-Mollevi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Maha Zohra Ladjemi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Ghislaine Béhar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Françoise Roquet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

André Pèlegrin

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

11 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

4826-4833

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19523913%20AND%20SRC:MED&resulttype=core&format=json

Biomarker conservation in primary and metastatic epithelial ovarian cancer

31 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

HER-2/neu as a predictive marker of response to breast cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Phase I and II clinical trials of trastuzumab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

New combinations with Herceptin in metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Herceptin: mechanisms of action and resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Cardiac toxicity of trastuzumab in metastatic breast cancer patients previously treated with high-dose chemotherapy: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Breast cancer vaccines: a clinical reality or fairy tale?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

7 January 2021

Cancer immunoprevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Anti-idiotype antibody vaccine therapy for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Anti-idiotype antibodies in cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 A resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Naturally occurring antibodies devoid of light chains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Single-domain antibody fragments with high conformational stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Induced refolding of a temperature denatured llama heavy-chain antibody fragment by its antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Antigen specificity and high affinity binding provided by one single loop of a camel single-domain antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Functional heavy-chain antibodies in Camelidae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Efficient tumor targeting by single-domain antibody fragments of camels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Multiple sequence alignment with the Clustal series of programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

IMGT, the international ImMunoGeneTics information system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Llama single domain antibodies as a tool for molecular mimicry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Hydrophobic Surface Burial Is the Major Stability Determinant of a Flat, Single-layer β-Sheet

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

A priori delineation of a peptide which mimics a discontinuous antigenic determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Novel engineered trastuzumab conformational epitopes demonstrate in vitro and in vivo antitumor properties against HER-2/neu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu--a new method of epitope definition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067

Exploring the Capacity of Minimalist Protein Interfaces: Interface Energetics and Affinity Maturation to Picomolar KD of a Single-domain Antibody with a Flat Paratope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.067